Cognitive Effects of Antiepileptic Drugs
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Antiepileptic drugs (AEDs) can adversely affect cognitive function by suppressing neuronal excitability or enhancing inhibitory neurotransmission. The main cognitive effects of AEDs are impaired attention, vigilance, and psychomotor speed, but secondary effects can manifest on other cognitive functions. Although the long-term use of AEDs can obviously elicit cognitive dysfunction in epilepsy patients, their cognitive effects over short periods of up to a year are inconclusive due to methodological problems. In general, the effects on cognition are worse for older AEDs (e.g., phenobarbital) than for placebo, nondrug condition, and newer AEDs. However, topiramate is the newer AED that has the greatest risk cognitive impairment irrespective of the comparator group. Since the cognitive impact of AEDs can be serious, clinicians should be alert to adverse events by evaluating cognitive function using screening tests. Adverse cognitive events of AEDs can be avoided by slow titration to the lowest effective dosage and by avoiding polytherapy.
Abstract
Antiepileptic drugs (AEDs) can adversely affect cognitive function by suppressing neuronal excitability or enhancing inhibitory neurotransmission. The main cognitive effects of AEDs are impaired attention, vigilance, and psychomotor speed, but secondary effects can manifest on other cognitive functions. Although the long-term use of AEDs can obviously elicit cognitive dysfunction in epilepsy patients, their cognitive effects over short periods of up to a year are inconclusive due to methodological problems. In general, the effects on cognition are worse for older AEDs (e.g., phenobarbital) than for placebo, nondrug condition, and newer AEDs. However, topiramate is the newer AED that has the greatest risk cognitive impairment irrespective of the comparator group. Since the cognitive impact of AEDs can be serious, clinicians should be alert to adverse events by evaluating cognitive function using screening tests. Adverse cognitive events of AEDs can be avoided by slow titration to the lowest effective dosage and by avoiding polytherapy.
참고문헌 (60)
- Motamedi G, "Epilepsy and cognition", Epilepsy Behav, 4, pp.S25~S38 (2003)
- Aldenkamp AP, "antiepileptic drugs and cognitive issues", Epilepsia, 44, pp.S21~S29 (2003)
- Ortinski P, "Cognitive side effects of antiepileptic drugs", Epilepsy Behav, 5, pp.S60~S65 (2004)
- Meador KJ, "Cognitive outcomes and predictive factors in epilepsy", Neurology, 58, pp.S21~S26 (2002)
- Bourgeois BF, "Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy", J Child Neurol, 19, pp.S15~S24 (2004)
- Loring DW, "Neuropsychological and behavioral effects of antiepilepsy drugs", Neuropsychol Rev, 17, pp.413~425 (2007)
- Carpay JA, "Complaints associatedwith the use of antiepileptic drugs: results from a community-based study", Seizure, 14, pp.198~206 (2005)
- Loring DW, "Cognitive side effects of antiepileptic drugs in children", Neurology, 62, pp.872~877 (2004)
- Holmes GL, "Epilepsy in the developing brain: lessons from the laboratory and clinic", Epilepsia, 38, pp.12~30 (1997)
- Garrard J, "Antiepileptic drug use in nursing home admissions", Ann Neurol, 54, pp.75~85 (2003)
- Smith DB, "Results of a nation-wide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone", Epilepsi, 28, pp.S50~S58 (1997)
- Prevey ML, "Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group", Arch Neurol, 53, pp.1008~1016 (1996)
- Pulliainen V, "Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients", Acta Neurol Scand, 89, pp.81~86 (1994)
- Meador KJ, "Comparative cognitive effects of carbamazepine and phenytoin in healthy adults", Neurology, 41, pp.1537~1540 (1991)
- Meador KJ, "Comparative cognitive effects of phenobarbital, phenytoin, and valproate in adults subjects", Neurology, 45, pp.1494~1499 (1995)
- Tonekaboni SH, "Tahbaz HS, Bahreynian SA, AghamohammadpoorM. Neurocognitive effects of phenobarbital discontinuation in epileptic children", Epilepsy Behav, 8, pp.145~148 (2006)
- Chadwick DW, "A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77", Neurology, 51, pp.1282~1288 (1998)
- Leach JP, "Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy", J Neurol Neurosurg Psychiatry, 62, pp.372~376 (1997)
- Meador KJ, "Differential cognitive effects of carbamazepine and gabapentin", Epilepsia, 40, pp.1279~1285 (1999)
- Salinsky MC, "Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers", Epilepsia, 43, pp.482~490 (2002)
- Mortimore C, "Effects of gabapentin on cognition and quality of life in patients with epilepsy", Seizure, 7, pp.359~364 (1998)
- Meador KJ, "Differential cognitive and behavioral effects of carbamazepine and lamotrigine", Neurology, 56, pp.1177~1182 (2001)
- Aldenkamp AP, "Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers", Epilepsia, 43, pp.19~26 (2002)
- Cohen AF, "Lamotrigine (BW430C), a potential anticonvulsant: Effects on the central nervous system in comparison with phenytoin and diazepam", Br J Clin Pharmacol, 20, pp.619~629 (1985)
- Hamilton MJ, "Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage", Epilepsia, 34, pp.166~173 (1993)
- Placidi F, "Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy", Acta Neurol Scand, 102, pp.81~86 (2000)
- Smith D, "Outcomes of add-on treatment with lamotrigine in partial epilepsy", Epilepsia, 34, pp.312~322 (1993)
- Pressler RM, "Robinson RO. Effect of lamotrigine on cognition in children with epilepsy", Neurology, 66, pp.1495~1499 (2006)
- Kang KH, "Cognitive profiles of lamotrigine in epilepsy patients: a comparative study with valproate", J Korean Epilepsy Soc, 10, pp.146~152 (2006)
- 서종근, "Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients", Journal of Clinical Neurology, 3(1), pp.31~37 (2007), 대한신경과학회
- Sabers A, "Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy", Acta Neurol Scand, 92, pp.19~27 (1995)
- Aikiä M, "Cognitiveeffects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up", Epilepsy Res, 11, pp.199~203 (1992)
- 박성파, "Oxcarbazepine을 복용한 간질환자의 인지기능: 신경심리검사 및 사건유발전위", 대한신경과학회지, 20(1), pp.27~33 (2002), 대한신경과학회
- Salinsky MC, "Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers", Epilepsy Behav, 8, pp.894~902 (2004)
- Donati F, "Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures", Neurology, 67, pp.679~682 (2006)
- Donati F, "The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures", Seizures, 16, pp.670~679 (2007)
- Mula M, "Topiramate and wordfinding difficulties in patients with epilepsy", Neurology, 60, pp.1104~1107 (2003)
- Lee S, "The effects of adjunctive topiramate on cognitive function in patients with epilepsy", Epilepsia, 44, pp.339~347 (2003)
- Kockelmann E, "Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients", Epilepsy Res, 54, pp.171~178 (2003)
- Fritz N, "Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy", Epilepsy Behav, 6, pp.373~381 (2005)
- Meador KJ, "CAPSS- 027 Study Group. Differential cognitive and behavioral effects of topiramate and valproate", Neurology, 60, pp.1483~1488 (2003)
- . Meador KJ, "Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers", Neurology, 64, pp.2108~2114 (2005)
- Salinsky MC, "Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers", Neurology, 64, pp.792~798 (2005)
- Blum D, "Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy", Neurology, 67, pp.400~406 (2006)
- Kim SY, "Cognitive effects of low-dose topiramate compared with oxcarbazepine in epilepsy patients", J Clin Neurol, 2, pp.126~133 (2006)
- Lee HW, "Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow- up", Epilepsy Behav, 8, pp.736~741 (2006)
- 박성파, "편두통 예방에서 토피라메이트와 연관된 인지기능장애", 대한신경과학회지, 23(1), pp.55~61 (2005), 대한신경과학회
- Kang HC, "The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy", Epilepsia, 48, pp.1716~1723 (2007)
- Dodrill CB, "Cognitive and qu ality of life effects of differing dosages of tiagabine in epilepsy", Neurology, 48, pp.1025~1031 (1997)
- Aikiä M, "Comparisonof the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies", Epilepsia, 47, pp.1121~1127 (2006)
- Dodrill CB, "Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy", Neurology, 43, pp.2501~2507 (1993)
- Kälviäinen R, "Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study", Arch Neurol, 52, pp.989~996 (1995)
- Berent S, "Abou- Khalil B. Zonisamide (CI-912) and cognition: results from preliminary study", Epilepsia, 28, pp.61~67 (1987)
- Wilensky AJ, "Zonisamide in epilepsy: a pilot study", Epilepsia, 26, pp.212~220 (1985)
- 박성파, "Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients", Journal of Clinical Neurology, 3(4), pp.175~180 (2007), 대한신경과학회
- Park SP, "Longterm cognitive and mood effects of zonisamide monotherapy in epilepsy patients", Epilepsy Behav, 12, pp.102~108 (2008)
- Hindmarch I, "A double-blind, placebo- and positive- internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers", Psychopharmacology( Berl), 183, pp.133~143 (2005)
- Ciesielski AS, "Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study", Epilepsy Behav, 9, pp.424~431 (2006)
- Meador KJ, "Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam", Neurology, 69, pp.2076~2084 (2007)
- Gomer B, "The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate", Epilepsy Behav, 10, pp.486~494 (2007)
